Goodwill - Co-Diagnostics Inc (NASDAQ:CODX)

Watchlist Manager

Watchlist

Price: 3 USD 2.04%

Market Cap: $6.3m

Co-Diagnostics Inc
Goodwill

Quarterly

Annual

Adjust for Inflation

Balance Sheet

Co-Diagnostics Inc
Goodwill Peer Comparison

	Goodwill	CAGR 3Y	CAGR 5Y	CAGR 10Y
Co-Diagnostics Inc NASDAQ:CODX	Goodwill N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Becton Dickinson and Co NYSE:BDX	Goodwill $26.6B	CAGR 3-Years 3%	CAGR 5-Years 2%	CAGR 10-Years 13%
Boston Scientific Corp NYSE:BSX	Goodwill $18.2B	CAGR 3-Years 12%	CAGR 5-Years 12%	CAGR 10-Years 11%
Stryker Corp NYSE:SYK	Goodwill N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Abbott Laboratories NYSE:ABT	Goodwill $24B	CAGR 3-Years 2%	CAGR 5-Years 1%	CAGR 10-Years 9%
Intuitive Surgical Inc NASDAQ:ISRG	Goodwill $348.1m	CAGR 3-Years 0%	CAGR 5-Years 1%	CAGR 10-Years 6%

Co-Diagnostics Inc
Glance View

Market Cap

6.3m USD

Industry

Health Care

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

View CODX Analysis

CODX Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

Co-Diagnostics Inc
NASDAQ:CODX

Co-Diagnostics Inc
Goodwill

Co-Diagnostics Inc
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Co-Diagnostics Inc
Glance View

See Also

Company

Help

Tools

Stocks

52 Week Range	2.36 37.8
Price Target

Co-Diagnostics Inc NASDAQ:CODX

Co-Diagnostics Inc Goodwill

Co-Diagnostics Inc Goodwill Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Co-Diagnostics Inc Glance View

See Also

Company

Help

Tools

Stocks

Co-Diagnostics Inc
NASDAQ:CODX

Co-Diagnostics Inc
Goodwill

Co-Diagnostics Inc
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Co-Diagnostics Inc
Glance View